Seasonal influenza and vaccination coverage
- PMID: 20713259
- DOI: 10.1016/j.vaccine.2010.08.027
Seasonal influenza and vaccination coverage
Abstract
Seasonal influenza represents a considerable public health burden, and annual vaccination represents the most effective preventive strategy for amelioration of this problem. Certain groups are at greatest risk, such as the young, the elderly, pregnant women, and those with chronic underlying medical conditions: the high-risk groups. Traditionally, annual vaccination has been targeted to people classified as being at high risk, particularly the elderly, but in recent years, there has been a broadening of vaccination recommendations to target larger numbers of people. This has recently culminated in the recommendation of "universal vaccination" in the USA (everyone over 6 months of age is recommended to receive the seasonal influenza vaccine). In this review, we will look at coverage rates in Europe and the USA, changes in vaccination guidelines, and the rationale for broadening vaccination recommendations. It is clear that often only modest improvements in vaccination coverage have occurred recently, with programs targeting risk groups, but some substantial increases in coverage have followed the broadening of USA vaccination recommendations to all persons under 18 years and to middle-aged healthy adults (> or =50 years). It is likely, however, that some of these increases may be because of the increased awareness related to the recent pandemic. It is unclear if increases in coverage will translate into public health benefits, but perhaps results will be similar to experiments with universal vaccination in Ontario, Canada, where increased coverage may have provided some reductions in healthcare use, fewer influenza-associated deaths, and even financial benefits.
2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.Vaccine. 2006 Nov 17;24(47-48):6812-22. doi: 10.1016/j.vaccine.2006.07.042. Epub 2006 Aug 4. Vaccine. 2006. PMID: 17034909
-
State-specific influenza vaccination coverage among adults--United States, 2006-07 influenza season.MMWR Morb Mortal Wkly Rep. 2008 Sep 26;57(38):1033-9. MMWR Morb Mortal Wkly Rep. 2008. PMID: 18818582
-
Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009.Vaccine. 2011 Jun 20;29(28):4632-7. doi: 10.1016/j.vaccine.2011.04.064. Epub 2011 May 6. Vaccine. 2011. PMID: 21550376
-
Increasing influenza vaccination coverage in recommended population groups in Europe.Expert Rev Vaccines. 2009 Apr;8(4):425-33. doi: 10.1586/erv.09.7. Expert Rev Vaccines. 2009. PMID: 19348558 Review.
-
The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns.Vaccine. 2010 Sep 7;28 Suppl 4:D3-13. doi: 10.1016/j.vaccine.2010.08.024. Vaccine. 2010. PMID: 20713258 Review.
Cited by
-
Factors associated to vaccination against influenza among elderly in a large Brazilian metropolis.PLoS One. 2015 Apr 13;10(4):e0123840. doi: 10.1371/journal.pone.0123840. eCollection 2015. PLoS One. 2015. PMID: 25874953 Free PMC article.
-
Influenza vaccines: Evaluation of the safety profile.Hum Vaccin Immunother. 2018 Mar 4;14(3):657-670. doi: 10.1080/21645515.2017.1423153. Epub 2018 Jan 30. Hum Vaccin Immunother. 2018. PMID: 29297746 Free PMC article. Review.
-
Next Generation of Computationally Optimized Broadly Reactive HA Vaccines Elicited Cross-Reactive Immune Responses and Provided Protection against H1N1 Virus Infection.Vaccines (Basel). 2021 Jul 16;9(7):793. doi: 10.3390/vaccines9070793. Vaccines (Basel). 2021. PMID: 34358209 Free PMC article.
-
Factors Affecting the Acceptance of Pandemic Influenza A H1N1 Vaccine amongst Essential Service Providers: A Cross Sectional Study.Vaccines (Basel). 2012 Dec 20;1(1):17-33. doi: 10.3390/vaccines1010017. Vaccines (Basel). 2012. PMID: 26343848 Free PMC article.
-
Targeting the skin for microneedle delivery of influenza vaccine.Adv Exp Med Biol. 2013;785:121-32. doi: 10.1007/978-1-4614-6217-0_13. Adv Exp Med Biol. 2013. PMID: 23456844 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical